Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Glucocorticoid receptor agonist comprising 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivatives having substituted oxy group

Glucocorticoid receptor agonist comprising 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivatives having substituted oxy group

US Patent 8426406 · Granted Apr 23, 2013

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Medical system and control method for medical system2025
Agent containing 4-phenylbutyrate, for preventing or treating presbyopia2025
Pavement condition rating method2024
Agent for preventing myopia, treating myopia, and/or preventing myopia progressi2023
Ursodeoxycholic acid-containing agent for treating or preventing presbyopia2022
Antibody inhibiting binding of VEGF to NRP12021
[4-(1,3,3-trimethyl-2-OXO-3,4-dihydro-1H-quinoxalin-7-yl)phenoxy]ethyloxy compou2019
[4-(1,3,3-trimethyl-2-oxo-3,4-dihydro-1H-quinoxalin-7-yl)phenoxy]ethyloxy compou2019
Compound having PARP inhibitory activity2015
Agent for treatment of dry eye characterized by combining P2Y2 receptor agonist 2015
1,2,3,4-tetrahydroquinoxaline compounds having glucocorticoid receptor binding a2015
1,2,3,4-tetrahydroquinoxaline compounds having glucocorticoid receptor binding a2015